Mild Side Effects These side effects are reported anecdotally and tend to resolve on their own within a few days of use or dose adjustment: Headache or light-headedness Mild nausea or upset stomach (especially with oral use) Fatigue or lethargy in the first few days of use Appetite changes (increase or decrease) Injection site irritation redness, swelling, or tenderness Mild dizziness, nausea, and local irritation are among the most commonly reported side effects of subcutaneous BPC-157 injection, typically resolving within 2472 hours. Milekic, T
KPV is often described as anti-inflammatory, but it is more useful to think of it as a peptide being studied for immune signaling modulation
The pain will often worsen when moving or touching the joint, and some patients have difficulty moving the joint due to limited range of motion
And someone should work with a clinician
The Connectivity Map (CMap) analysis by Iorio et al
These allow accurate measurement of volumes like 0.12mL or 0.15mL, which are common for mid-range peptide doses
